CARDIA, MARIA CRISTINA
 Distribuzione geografica
Continente #
EU - Europa 144.851
NA - Nord America 4.106
AS - Asia 755
AF - Africa 8
SA - Sud America 3
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 149.725
Nazione #
IT - Italia 143.099
US - Stati Uniti d'America 4.054
UA - Ucraina 541
CN - Cina 529
SE - Svezia 428
DE - Germania 357
GB - Regno Unito 164
FI - Finlandia 120
SG - Singapore 96
FR - Francia 56
CA - Canada 34
IN - India 32
KR - Corea 23
VN - Vietnam 23
IR - Iran 22
BE - Belgio 19
RU - Federazione Russa 18
VG - Isole Vergini Britanniche 16
PT - Portogallo 12
PK - Pakistan 10
PL - Polonia 10
NL - Olanda 7
TR - Turchia 6
IE - Irlanda 5
EG - Egitto 4
SA - Arabia Saudita 4
DK - Danimarca 3
MU - Mauritius 3
ES - Italia 2
HU - Ungheria 2
ID - Indonesia 2
IL - Israele 2
MD - Moldavia 2
RO - Romania 2
A1 - Anonimo 1
AU - Australia 1
BG - Bulgaria 1
BO - Bolivia 1
BR - Brasile 1
CR - Costa Rica 1
CZ - Repubblica Ceca 1
HK - Hong Kong 1
IQ - Iraq 1
JO - Giordania 1
JP - Giappone 1
LK - Sri Lanka 1
LT - Lituania 1
MX - Messico 1
PE - Perù 1
RS - Serbia 1
TN - Tunisia 1
UZ - Uzbekistan 1
Totale 149.725
Città #
Cagliari 142.191
Chandler 494
Fairfield 429
Woodbridge 371
Nyköping 315
Jacksonville 296
Ann Arbor 282
Houston 230
Ashburn 209
Dearborn 208
Wilmington 199
Seattle 168
Cambridge 134
Boardman 99
New York 95
Nanjing 91
Shanghai 85
Beijing 65
Boston 56
Helsinki 52
Milan 47
Rome 43
Singapore 42
Nanchang 37
Guangzhou 36
Redwood City 33
Shenyang 33
Toronto 26
Changsha 24
Parma 23
Dong Ket 22
San Diego 22
Seoul 22
Hebei 20
Verona 19
Jinan 18
Nürnberg 18
Brussels 17
Jiaxing 16
Road Town 16
Sassari 16
Orange 14
Tianjin 14
Mountain View 13
Norwalk 13
Auburn Hills 12
Padova 12
Naples 11
Florence 9
Lodz 9
London 9
Los Angeles 9
Augusta 8
Bari 8
Cosenza 8
Hangzhou 8
Hefei 8
Herndon 8
Kunming 8
Rende 8
Taizhou 8
Washington 8
Zhengzhou 8
Saint Petersburg 7
Chicago 6
Ningbo 6
Pavia 6
Salerno 6
Camden 5
Catania 5
Genoa 5
Portici 5
Porto 5
Pune 5
San Mateo 5
Siracusa 5
Turin 5
Zerfalìu 5
Bologna 4
Capoterra 4
Costa Mesa 4
Istanbul 4
Lecce 4
Millbury 4
Modena 4
Mumbai 4
Ottawa 4
Palermo 4
Pisa 4
Rio Tinto 4
Tertenìa 4
Trieste 4
Wuhan 4
Ardabil 3
Beaverton 3
Belfast 3
Bergamo 3
Berlin 3
Bosco Marengo 3
Boydton 3
Totale 146.994
Nome #
Inhalable polymer-glycerosomes as safe and effective carriers for rifampicin delivery to the lungs 4.363
Formulation and characterization studies of trimethyl chitosan / sodium alginate nanoparticles for targeted drug delivery 4.255
3-Acetyl-2,5-diaryl-2,3-dihydro-1,3,4-oxadiazoles: A new scaffold for the selective inhibition of monoamine oxidase B 3.731
Investigating the interactions of resveratrol with phospholipid vesicle bilayer and the skin: NMR studies and confocal imaging 3.634
Nanoincorporation of curcumin in polymer-glycerosomes and evaluation of their in vitro-in vivo suitability as pulmonary delivery systems 3.577
A novel series of 3,4-disubstituted dihydropyrazoles: Synthesis and evaluation for MAO enzyme inhibition 3.372
Preparazione di nanoparticelle di TMC per il rilascio di farmaci a livello oculare 3.250
Identification of HIV-1 reverse transcriptase dual inhibitors by a combined shape-, 2D-fingerprint- and pharmacophore-based virtual screening approach 3.152
Sintesi e caratterizzazione chimico-fisica di un derivato del chitosano per la realizzazione di sistemi nanoparticellari 3.132
Preparation and characterization of TMC nanoparticles for colon specific drug delivery 3.103
Synthesis And Characterization Of A Chitosan Derivative For The Preparation Of Nanoparticles 2.984
Design and synthesis of new isatin derivatives as HIV-1 reverse transcriptase associated ribonuclease H inhibitors 2.979
PREPARATION OF TMC NANOPARTICLES FOR OCULAR DELIVERY 2.942
Synthesis and biological assessment of novel 2-thiazolylhydrazones and computational analysis of their recognition by monoamine oxidase B 2.932
Synthesis of new 3-aryl-4,5-dihydropyrazole-1-carbothioamide derivatives. An investigation on their ability to inhibit monoamine oxidase 2.834
null 2.749
Physico-chemical characterization of succinyl chitosan-stabilized liposomes for the oral co-delivery of quercetin and resveratrol 2.727
NANOPARTICELLE A BASE DI TMC E SA PER LA VEICOLAZIONE NOSE TO BRAIN 2.592
SINTESI DI TMC A DIVERSO GRADO DI QUATERNIZZAZIONE PER LA REALIZZAZIONE DI SISTEMI NANOPARTICELLARI 2.500
Synthesis and characterization of new phthalhydrazothiazole derivatives: A preliminary investigation on their activity against hepatocellular carcinoma 2.398
PREPARAZIONE E CARATTERIZZAZIONE DI SISTEMI NANOPARTICELLARI DI TMC PER LA VEICOLAZIONE DI UN AGENTE ANTINFIAMMATORIO FITOTERAPICO MIRATO AL COLON 2.383
Chalcones as novel dual inhibitors of HIV-1 reverse transcriptase 2.228
Trimethyl chitosan hydrogel nanoparticles for progesterone delivery in neurodegenerative disorders 2.186
3-[2-(4-aryl-1,3-thiazol-2-yl)hydrazin-1-ylidene]-1H-indol-2-ones as new potential dual inhibitors of polimerase and ribonuclease HIV-1 RT associated function 2.125
Preparazione e caratterizzazione di formulazioni cosmetiche contenenti olio di Neem 2.121
Nanoparticelle per la veicolazione nasale del Progesterone per il trattamento della malattia di Alzheimer 2.095
1H NMR study of the interaction of trans-resveratrol with soybean phosphatidylcholine liposomes 2.087
SYNTHESIS AND CHARACTERIZATION OF A CHITOSAN DERIVATIVE FOR THE PREPARATION OF NANOPARTICLES 2.081
Preparation and Characterization of TMC/SA nanoparticles for nose to brain drug delivery 2.054
Exploring new scaffolds for the inibition of the Ribonuclease H function of RT HIV-1 2.041
New promising scaffolds for the inhibition of monoamine oxidase B 2.029
null 1.949
Design and synthesis of new Isatin derivatives as HIV-1 Reverse Transcriptase associated Ribonuclease H inhibitors twenty-fourth 1.940
Approcci formulativi per ottimizzare l’incapsulazione nanoparticellare della Curcumina 1.897
In vitro activity of 2-cyclohexylidenhydrazo-4-phenil-thiazole compared with those of amphotericin b and fluconazole against clinical isolates of Candida spp. and fluconazole-resistant Candida albicans 1.783
Synthesis and anti-microbial activity evaluation of some new 1-benzoyl-isothiosemicarbazides. 1.741
Identification of HIV-1 reverse trascriptase dual inhibitors by a combined shape-, 2D fingerprint and pharmacophore-based virtual screening approch 1.727
Design of new inhibitors of the HIV-1 Reverse Transcriptase associated Ribonuclease H function: a synthetic approach 1.705
Synthesis, semipreparative HPLC separation, biological evaluation, and 3D-QSAR of hydrazothiazole derivatives as human monoamine oxidase B inhibitors 1.687
Design, synthesis and biolgical activity evaluation of new HIV-1 reverse transcriptase dual inhibitors 1.643
Identification of new scaffolds for the inhibition of HIV-1 Reverse Transcriptase associated Ribonuclease H function by means of shape based similarity screening 1.531
Synthesis and anti-microbial activity of isothiosemicarbazones and cyclic analogues 1.493
Exploring new scaffolds for the inhibition of the Ribonuclease H function of RT HIV-1 1.436
Synthesis and antimicrobial activity of novel arylidenisothiosemicarbazones 1.424
SYNTHESIS, MOLECULAR MODELLING, INHIBITORY ACTIVITY, AND SELECTIVITY TOWARDS MONOAMINE OXIDASE OF NEW HETEROCYCLIC SCAFFOLDS 1.416
null 1.415
null 1.406
Design, synthesis and biological activity evaluation of new HIV-1 reverse transcriptase dual inhibitors 1.403
Attività fungicida di analoghi ciclici isotiosemicarbazonici nei confronti di isolati clinici di Candida spp. 1.363
Effetti sulla attività di AmB nei confronti di biofilm di C. albicans in seguito ad esposizione a EM01D2 e fluconazolo. 1.344
Derivati ciclici isotiosemicarbazonici come approccio alternativo nella terapia delle infezioni sostenute da Candida spp. 1.222
Terapia delle infezioni sostenute da Candida spp.: nuovi approcci mediante derivati isotiosemicarbazonici. 1.177
Shape based computer aided similarity screening: a valid tool in the discovery of new scaffolds for the inhibition of HIV-1 reverse transcriptase associated ribonuclease H function 1.166
Transcutol® p containing slns for improving 8-methoxypsoralen skin delivery 1.067
Synthesis of new arylidencycloalkylpyrazoles of potential biological interest 1.004
null 943
An investigation of the biological effect of structural modifications of isothiosemicarbazones and their cyclic analogues 936
Characterization of 2,5-diaryl-1,3,4-oxadiazolines by multinuclear magnetic resonance and DFT calculations. Investigation on a case of very remote Hammett correlation 930
Progettazione e sintesi di 4-(5-ariliden-3-metil-4-ossotiazolidin-2-ilidenamino)benzensulfonamidi e 4-(5-alchiliden-3-metil-4-ossotiazolidin-2-ilidenammino)benzensulfonamidi quali potenziali inibitori selettivi delle ciclossigenasi 2 910
Synthesis, molecular modelling, inhibitory acivity, and selectivity towards monoamine oxidase of new heterocyclic scaffold 905
Computational approaches for discovery and optimization of monoamine oxidase B inhibitors 884
Synthesis and biological evaluation of some differently substituted 9,10-anthracenediones 869
null 818
CoMFA studies of non-covalent monoamine oxidase inhibitors 807
1-benzenesulfonamide-1(H)-pyrazoles and 3-benzenesulfonamide-4-tiazolidinones, two promising scaffolds for the design of cycloxygenase inhibitors 804
Sintesi di cicloalchilidenidrazo-4-ariltiazoli ad elevata attività inibitrice selettiva sulla isoforma B delle monoammino ossidasi 777
Combining induced fit docking and molecular dynamics simulations to predict the binding mode of new monoamine oxidase B inhibitors 773
1-acetyl-2,5-diaryl-2,3-dihydro-1,3,4-oxadiazole; a new scaffold for monoaminoxidase inhibitors: design, synthesis, and biological properties 760
Tri-substituted thiazolines as promising scaffolds for the design of efficient COX inhibitors 757
Attività di un derivato isotiosemicarbazonico ciclico nei confronti di biofilm di Candida albicans FLC-S e FLC-R in combinazione con AMB 750
Synthesis and antimicrobial activity of novel arylideneisothiosemicarbazones 739
null 735
Computational and experimental study of non-covalent monoamine oxidase inhibitors 725
Novel MAO-B selective inhibitors developed using computational methods 714
Synthesis, molecular modeling studies and selective inhibitory activity against MAO of N1-propanoyl-3,5-diphenyl-4,5-dihydro-(1H)-pyrazole derivatives 709
null 693
Topoisomerase I: synthesis of a new class of potential inhibitors 690
Proniosomal formulation encapsulating pomegranate peel extract for nutraceutical applications 676
Aumento della sensibilità all’AmB di biofilm di Candida albicans fluconazolo-resistente nell’impiego combinato con derivati ciclici isotiosemicarbazonici 626
Repurposing Pomalidomide as a Neuroprotective Drug: Efficacy in an Alpha-Synuclein-Based Model of Parkinson's Disease 626
null 617
null 610
Studio dell’attività di analoghi ciclici isotiosemicarbazonici nei confronti di isolati clinici di Aspergillus spp 583
Strategie alternative per la profilassi delle infezioni sostenute da Candida albicans contratte in ambiente ospedaliero mediante isotiosemicarbazoni ciclici 578
Preparazione di nanoparticelle TMC/Alginato per la veicolazione al SNC 567
Isothiosemicarbazones as alternative approach to the therapy of infections sustained by Candida albicans 536
Studio della attività di una nuova classe di isotiosemicarbazoni nei confronti di Aspergillus spp. di isolamento clinico. 498
Pulmonary delivery of curcumin and beclomethasone dipropionate in a multicomponent nanosuspension for the treatment of bronchial asthma 497
Synthesis of new arylidencycloalkylpyrazoles of biological interest 484
Needle-Free Jet Injectors and Nanosuspensions: Exploring the Potential of an Unexpected Pair 377
Nanocrystals as an effective strategy to improve Pomalidomide bioavailability in rodent 308
Isonicotinoylhydrazothiazoles and isonicotinoyl-N-4-substituted thiosemicarbazides: Synthesis, characterization, and anti-mycobacterial activity 271
Impact of solid lipid nanoparticles on 3T3 fibroblasts viability and lipid profile: The effect of curcumin and resveratrol loading 268
New cycloalkylpyrazoles as potential cyclooxygenase inhibitors 238
Characterization of 2,5-diaryl-1,3,4-oxadiazolines by multinuclear magnetic resonance and density functional theory calculations. Investigation on a case of very remote Hammett correlation 236
Selective inhibitory activity against MAO and molecular modeling studies of 2-thiazolylhydrazone derivatives 227
Bentonite- and Palygorskite-Based Gels for Topical Drug Delivery Applications 183
Nanosuspension-Based Dissolvable Microneedle Arrays to Enhance Diclofenac Skin Delivery 173
Clay-Based Hydrogels as Drug Delivery Vehicles of Curcumin Nanocrystals for Topical Application 168
Synthesis, Molecular Modeling Studies, and Selective Inhibitory Activity against Monoamine Oxidase of 1-Thiocarbamoyl-3,5-diaryl-4,5-dihydro-(1H)- pyrazole Derivatives 144
Totale 149.694
Categoria #
all - tutte 169.886
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 169.886


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019384 0 0 0 0 0 0 0 0 0 0 0 384
2019/202027.692 1.396 1.197 324 592 9.007 6.422 3.507 904 765 995 893 1.690
2020/202140.495 1.671 1.591 2.139 9.915 7.834 4.334 3.610 2.304 1.159 2.327 2.291 1.320
2021/20227.147 991 765 320 378 597 490 481 334 590 590 805 806
2022/202312.131 945 1.574 1.399 1.156 816 1.103 753 965 670 997 1.198 555
2023/202413.441 494 654 1.153 916 1.496 2.115 2.025 1.026 819 715 1.134 894
Totale 149.935